Standout Papers

mRNA vaccine–induced neoa... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
    2020 309 citations Gal Cafri, Jared J. Gartner et al. Journal of Clinical Investigation profile →

Immediate Impact

13 by Nobel laureates 27 from Science/Nature 75 hit
Sub-graph 1 of 21

Citing Papers

mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 HitNobel
Translating p53-based therapies for cancer into the clinic
2024 Hit

Works of Biman C. Paria being referenced

mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
2020 Hit
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
2019

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Biman C. Paria 1.4k 1.4k 1.0k 861 553 32 3.3k
Attila Braun 1.7k 1.2× 1.0k 0.8× 568 0.6× 408 0.5× 474 0.9× 75 4.4k
Stefan Kraft 645 0.5× 904 0.7× 609 0.6× 268 0.3× 411 0.7× 30 2.4k
Akito Maeda 2.6k 1.9× 600 0.4× 1.6k 1.6× 668 0.8× 1.4k 2.5× 36 4.8k
Joshua T. Jones 1.7k 1.3× 1.6k 1.1× 271 0.3× 231 0.3× 679 1.2× 27 3.1k
Amit Jairaman 1.1k 0.8× 515 0.4× 847 0.8× 235 0.3× 252 0.5× 21 2.6k
Hitoshi Matsushime 2.8k 2.0× 527 0.4× 294 0.3× 1.9k 2.2× 370 0.7× 27 4.6k
Monika Vig 1.3k 0.9× 2.3k 1.6× 866 0.9× 101 0.1× 1.0k 1.9× 20 3.4k
Wen Xu 1.1k 0.8× 1.3k 0.9× 189 0.2× 157 0.2× 549 1.0× 30 2.3k
Guo N. Huang 2.2k 1.6× 1.3k 1.0× 235 0.2× 149 0.2× 714 1.3× 48 3.5k
Tsuneaki Sakata 916 0.7× 328 0.2× 630 0.6× 367 0.4× 425 0.8× 61 2.1k

All Works

Loading papers...

Rankless by CCL
2026